View of WHEN USING PROGRAM CHEMOTHERAPY IN PATIENTS WITH HEMOBLASTOSES, THE INCIDENCE AND STRUCTURE OF INFECTIOUS COMPLICATIONS

Return to Article Details WHEN USING PROGRAM CHEMOTHERAPY IN PATIENTS WITH HEMOBLASTOSES, THE INCIDENCE AND STRUCTURE OF INFECTIOUS COMPLICATIONS Download Download PDF